Showing results (421-430 of 841) with videos related to
Sort By:
Pageof 85
Quintessence International (Berlin, Germany : 1985)|December 25, 2008
Oral effects of nonmyeloablative stem cell transplantation: a prospective observational studySharon Elad, Michael Y Shapira, Sandre McNeal, et al.Bone Marrow Transplantation|September 4, 2003
A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantationM Y Shapira, R Or, I B Resnick, et al.Breast Cancer Research and Treatment|January 14, 2000
Telomerase activity in ductal carcinoma in situ of the breastB Shpitz, S Zimlichman, R Zemer, et al.Bone Marrow Transplantation|July 6, 2004
Low transplant-related mortality with allogeneic stem cell transplantation in elderly patientsM Y Shapira, I B Resnick, M Bitan, et al.Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|November 21, 2021
The polarization dependence of 2D IR cross-peaks distinguishes parallel-stranded and antiparallel-stranded DNA G-quadruplexesDavid A Price, Poornima Wedamulla, Tayler D Hill, et al.The Journal of Physical Chemistry. B|April 7, 2021
Cooperative Demolition: Water's Disruption of Structures in Deep Eutectic SolventsHaley M Booth, Dylan D Moran, Janet Gonzalez, et al.Journal of Sports Sciences|December 24, 2019
Cut points of the Actigraph GT9X for moderate and vigorous intensity physical activity at four different wear locationsMatthew B Rhudy, Scott B Dreisbach, Matthew D Moran, et al.Clinical Transplantation|April 28, 2004
Tube thoracostomy during allogeneic stem cell transplantation does not carry an increased risk for infections or bleedingD Barkan, S Nusair, I B Resnick, et al.Clinical Therapeutics|April 28, 2004
Intrahepatic arterial administration of low-dose methotrexate in patients with severe hepatic graft-versus-host disease: an open-label, uncontrolled trialAllan I Bloom, Michael Y Shapira, Reuven Or, et al.British Journal of Haematology|November 20, 2002
Intra-arterial catheter directed therapy for severe graft-versus-host diseaseMichael Y Shapira, Allan I Bloom, Reuven Or, et al.Pageof 85